Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2090) 2090
Publication (231) 231
Newsletter (32) 32
Book Review (12) 12
Magazine Article (10) 10
Book / eBook (9) 9
Book Chapter (7) 7
Conference Proceeding (4) 4
Data Set (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (1663) 1663
humans (1631) 1631
candidiasis, vulvovaginal - microbiology (875) 875
adult (725) 725
index medicus (639) 639
vagina - microbiology (508) 508
candidiasis (468) 468
candidiasis, vulvovaginal - drug therapy (453) 453
microbiology (447) 447
middle aged (406) 406
candida - isolation & purification (366) 366
vaginitis (348) 348
adolescent (344) 344
animals (341) 341
candidiasis, vulvovaginal - diagnosis (328) 328
candida albicans (322) 322
infectious diseases (311) 311
women (291) 291
antifungal agents - therapeutic use (289) 289
candida albicans - isolation & purification (281) 281
infections (271) 271
pregnancy (268) 268
vulvovaginal candidiasis (266) 266
albicans (257) 257
candidiasis, vulvovaginal - epidemiology (257) 257
prevalence (232) 232
antifungal agents - pharmacology (230) 230
epidemiology (224) 224
mycology (217) 217
candidiasis, vulvovaginal (216) 216
health aspects (205) 205
recurrence (205) 205
mice (200) 200
candida (195) 195
fluconazole (193) 193
immunology (188) 188
male (188) 188
candida albicans - drug effects (183) 183
microbial sensitivity tests (182) 182
young adult (177) 177
bacterial vaginosis (176) 176
research article (176) 176
antifungal agents (171) 171
risk factors (166) 166
infection (162) 162
candida - drug effects (159) 159
obstetrics & gynecology (157) 157
candidiasis - microbiology (151) 151
research (151) 151
candidiasis, vulvovaginal - immunology (144) 144
candida - classification (140) 140
virulence (125) 125
aged (124) 124
vaginitis - microbiology (124) 124
diagnosis (123) 123
yeast (122) 122
vaginal candidiasis (121) 121
mycoses (120) 120
vagina (119) 119
vulvo-vaginal candidiasis (119) 119
candida albicans - pathogenicity (117) 117
candidiasis, vulvovaginal - etiology (113) 113
vaginal smears (111) 111
susceptibility (110) 110
fungi (109) 109
analysis (108) 108
vaginosis, bacterial - microbiology (107) 107
antifungal agents - administration & dosage (101) 101
candidiasis, vulvovaginal - complications (101) 101
candida albicans - genetics (97) 97
care and treatment (97) 97
treatment outcome (97) 97
pharmacology & pharmacy (95) 95
prospective studies (95) 95
drug resistance, fungal (92) 92
medicine (92) 92
candidiasis, vulvovaginal - prevention & control (91) 91
medical research (91) 91
therapy (90) 90
candida albicans - growth & development (88) 88
trichomonas vaginitis - diagnosis (88) 88
identification (87) 87
disease models, animal (86) 86
candidiasis - drug therapy (85) 85
candida albicans - immunology (84) 84
candidiasis, vulvovaginal - pathology (84) 84
pathogenesis (82) 82
fluconazole - therapeutic use (81) 81
pregnancy complications, infectious - microbiology (81) 81
rats (81) 81
resistance (79) 79
vaginosis, bacterial - diagnosis (79) 79
medicine, general & internal (78) 78
fungal infections (77) 77
colonization (74) 74
fluconazole - pharmacology (73) 73
vaginosis (72) 72
dermatology (71) 71
medicine, experimental (71) 71
incidence (70) 70
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1780) 1780
German (68) 68
Spanish (59) 59
Polish (45) 45
Russian (41) 41
Chinese (32) 32
Bulgarian (30) 30
French (23) 23
Italian (21) 21
Czech (17) 17
Portuguese (11) 11
Turkish (6) 6
Danish (5) 5
Dutch (5) 5
Swedish (4) 4
Hungarian (3) 3
Japanese (3) 3
Romanian (2) 2
Slovak (2) 2
Croatian (1) 1
Persian (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Recurrent vulvovaginal candidiasis
by Sobel, Jack D., MD
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2016, Volume 214, Issue 1, pp. 15 - 21
Recurrent vulvovaginal candidiasis (RVVC) is a common cause of significant morbidity in women in all strata of society affecting millions of women worldwide.... 
Obstetrics and Gynecology | Candida vaginitis | vulvovaginal candidiasis | vaginal candidosis | antifungals | antimycotics | DIAGNOSIS | MANNOSE-BINDING LECTIN | BORIC-ACID | FLUCONAZOLE THERAPY | CANDIDOSIS | GENE POLYMORPHISM | OBSTETRICS & GYNECOLOGY | PATHOGENESIS | WOMEN | VAGINITIS | ALBICANS | Probiotics | Recurrence | Candidiasis, Vulvovaginal - immunology | Genetic Predisposition to Disease | Humans | Candidiasis, Vulvovaginal - genetics | Female | Candidiasis, Vulvovaginal - microbiology | Candidiasis, Vulvovaginal - drug therapy | Drug Resistance, Fungal | Antifungal Agents - therapeutic use | Candidiasis, Vulvovaginal - diagnosis | Fluconazole | Drug resistance | Candidiasis, Vulvovaginal
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors
by Gonçalves, Bruna and Ferreira, Carina and Alves, Carlos Tiago and Henriques, Mariana and Azeredo, Joana and Silva, Sónia
Critical Reviews in Microbiology, ISSN 1040-841X, 11/2016, Volume 42, Issue 6, pp. 905 - 927
Vulvovaginal candidiasis (VVC) is an infection caused by Candida species that affects millions of women every year. Although Candida albicans is the main cause... 
Behavioral factors | host factors | Candida species | virulence factors | vaginal infection | SEXUALLY-TRANSMITTED DISEASES | HUMAN EPITHELIAL-CELLS | MANNOSE-BINDING LECTIN | RECURRENT CANDIDAL VAGINITIS | MICROBIOLOGY | CLINICALLY RELEVANT MICROORGANISMS | BACTERIAL VAGINOSIS | WHITE-OPAQUE TRANSITION | GENE-EXPRESSION | SECRETED ASPARTYL PROTEINASE | FEMALE REPRODUCTIVE-TRACT | Pregnancy | Candida - classification | Candida - genetics | Candidiasis, Vulvovaginal - epidemiology | Candida - physiology | Humans | Risk Factors | Female | Candidiasis, Vulvovaginal - microbiology | Candida - isolation & purification
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Biofilms and vulvovaginal candidiasis
by Rodríguez-Cerdeira, Carmen and Gregorio, Miguel Carnero and Molares-Vila, Alberto and López-Barcenas, Adriana and Fabbrocini, Gabriella and Bardhi, Brunilda and Sinani, Ardiana and Sánchez-Blanco, Elena and Arenas-Guzmán, Roberto and Hernandez-Castro, Rigoberto
Colloids and Surfaces B: Biointerfaces, ISSN 0927-7765, 02/2019, Volume 174, pp. 110 - 125
Candida species, including , are part of the mucosal flora of most healthy women, and inhabit the gastrointestinal and genitourinary tracts. Under favourable... 
Vulvovaginal candidiasis | Candida albicans | Candida spp | Antifungals | Probiotics | Biofilms | MATERIALS SCIENCE, BIOMATERIALS | ALBICANS BIOFILM | ANTIFUNGAL ACTIVITY | CHEMISTRY, PHYSICAL | AMPHOTERICIN-B | LACTOBACILLUS-RHAMNOSUS GR-1 | BACTERIAL VAGINOSIS | REUTERI RC-14 | MURINE MODEL | BIOPHYSICS | ASPARTYL PROTEINASES | IN-VITRO ACTIVITY | FLUCONAZOLE | Antifungal Agents - pharmacology | Biofilms - drug effects | Candida - pathogenicity | Humans | Biofilms - growth & development | Candidiasis, Vulvovaginal - pathology | Female | Candidiasis, Vulvovaginal - microbiology | Candidiasis, Vulvovaginal - drug therapy | Drug Resistance, Fungal
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects
by Cassone, A
BJOG: An International Journal of Obstetrics & Gynaecology, ISSN 1470-0328, 05/2015, Volume 122, Issue 6, pp. 785 - 794
Although a number of fungal species belonging to the genus C andida can cause acute vulvovaginal infection ( VVC ), C andida albicans is by far the most... 
andida albicans | pathogenesis | vulvovaginal candidiasis | immunity | vaccines | Candida albicans | PROTECTION | MANNOSE-BINDING LECTIN | MUCOSAL IMMUNITY | NLRP3 INFLAMMASOME | GENE POLYMORPHISM | OBSTETRICS & GYNECOLOGY | WOMEN | EPITHELIAL-CELLS | IN-VITRO MODEL | HOST-DEFENSE | SECRETED ASPARTYL PROTEINASE | Candida albicans - pathogenicity | Candidiasis, Vulvovaginal - prevention & control | Recurrence | Candidiasis, Vulvovaginal - immunology | Fungal Vaccines | Humans | Female | Candidiasis, Vulvovaginal - microbiology | Candida albicans - immunology | Mycoses | Health aspects | Vaccines | Fungal infections | Pathogenesis | Medical immunity
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Guideline: Vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis)
by Mendling, Werner
Mycoses, ISSN 0933-7407, 03/2015, Volume 58, Issue 1, pp. 1 - 15
The oestrogenised vagina is colonised by Candida species in at least 20% of women; in late pregnancy and in immunosuppressed patients, this increases to at... 
DIABETES-MELLITUS | ORAL FLUCONAZOLE | EPIDEMIOLOGIC SURVEY | MANNOSE-BINDING LECTIN | VULVOVAGINAL CANDIDIASIS | CLINICAL-ASPECTS | MYCOLOGY | ALBICANS | SACCHAROMYCES-CEREVISIAE | POTENTIAL ROLE | NONPREGNANT WOMEN | DERMATOLOGY | Microscopy, Phase-Contrast | Humans | Vaginal Discharge | Candidiasis, Vulvovaginal - drug therapy | Antifungal Agents - therapeutic use | Candidiasis, Vulvovaginal - diagnosis | Microbial Sensitivity Tests | Pregnancy | Candida albicans - drug effects | Pregnancy Complications, Infectious - drug therapy | Female | Candidiasis, Vulvovaginal - microbiology | Pregnancy Complications, Infectious - microbiology | Antifungal Agents - administration & dosage | Germany | Infant, Newborn | Candida glabrata - drug effects | Pregnancy Complications, Infectious - diagnosis | Index Medicus
Journal Article
Details down arrow
6. Full Text Diverse vaginal microbiomes in reproductive-age women with vulvovaginal candidiasis
by Liu, Mu-Biao and Xu, Su-Rong and He, Yan and Deng, Guan-Hua and Sheng, Hua-Fang and Huang, Xue-Mei and Ouyang, Cai-Yan and Zhou, Hong-Wei
PLoS ONE, ISSN 1932-6203, 11/2013, Volume 8, Issue 11, p. e79812
Vulvovaginal candidiasis (VVC) is one of the most prevalent vaginal infectious diseases, and there are controversial reports regarding the diversity of the... 
GRAM STAIN | FLORA | MULTIDISCIPLINARY SCIENCES | Humans | Middle Aged | Microbiota - drug effects | Anti-Infective Agents - therapeutic use | Biodiversity | Candidiasis, Vulvovaginal - drug therapy | Young Adult | Anti-Infective Agents - administration & dosage | Adult | Female | High-Throughput Nucleotide Sequencing | Vagina - microbiology | Candidiasis, Vulvovaginal - microbiology | Metagenome | Cluster Analysis | Infection | Microbiota (Symbiotic organisms) | RNA | Analysis | Candidiasis, Vulvovaginal | Nucleotide sequencing | Biological diversity | DNA sequencing | Health care | Candidiasis | rRNA 16S | Yeast | Mixed infection | Communities | Taxonomy | Microbiomes | Infections | Vaginosis | Species diversity | Microbiota | Microorganisms | Phylogenetics | Age | Species richness | Public health | Community structure | Biodegradation | Gynecology | Environmental health | Vagina | Abundance | Ecology | Patients | Obstetrics | Medicine | Infectious diseases | Hospitals | Womens health | Methods
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14 exhibit strong antifungal effects against vulvovaginal candidiasis‐causing Candida glabrata isolates
by Chew, S.Y and Cheah, Y.K and Seow, H.F and Sandai, D and Than, L.T.L
Journal of Applied Microbiology, ISSN 1364-5072, 05/2015, Volume 118, Issue 5, pp. 1180 - 1190
AimsThis study investigates the antagonistic effects of the probiotic strains Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 against vulvovaginal... 
antifungal | vulvovaginal candidiasis | probiotic | 14 | actobacillus rhamnosus | actobacillus reuteri | andida glabrata | Probiotic | Vulvovaginal candidiasis | Candida glabrata | Antifungal | Lactobacillus rhamnosus GR-1 | Lactobacillus reuteri RC-14 | SURFACE-PROPERTIES | BACTERIA | MICROBIOLOGY | COAGGREGATION | PARACASEI | ADHESION | INHIBITION | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | ABILITY | RESISTANCE | ALBICANS | SUBSTANCE | Probiotics - administration & dosage | Lactobacillus reuteri - physiology | Humans | Female | Candidiasis, Vulvovaginal - microbiology | Lactobacillus rhamnosus - physiology | Candida glabrata - growth & development | Antibiosis | Candida glabrata - drug effects | Probiotics | Exhibitions | Antifungal agents | Candidiasis, Vulvovaginal | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text A comparative investigation of azole susceptibility in Candida isolates from vulvovaginal candidiasis and recurrent vulvovaginal candidiasis patients in Ghana
by Adjapong, Gloria and Hale, Marie and Garrill, Ashley
Medical Mycology, ISSN 1369-3786, 08/2017, Volume 55, Issue 6, pp. 686 - 689
Abstract Vulvovaginal candidiasis (VVC) and recurrent vulvovaginal candidiasis (RVVC) affect millions of women and are typically treated with azoles. We know... 
vulvovaginal candidiasis | Ghana | recurrent vulvovaginal candidiasis | azole susceptibility | Candida | INFECTIOUS DISEASES | VETERINARY SCIENCES | MYCOLOGY | Antifungal Agents - pharmacology | Microbial Sensitivity Tests | Humans | Female | Candida - drug effects | Candidiasis, Vulvovaginal - microbiology | Azoles - pharmacology | Candida - isolation & purification | Drug Resistance, Fungal
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Molecular Characterization of Highly Susceptible Candida africana from Vulvovaginal Candidiasis
by Yazdanparast, Seyed Amir and Khodavaisy, Sadegh and Fakhim, Hamed and Shokohi, Tahereh and Haghani, Iman and Nabili, Mojtaba and Gholami, Haniyeh and Ahmadi, Imaneh and Badali, Hamid
Mycopathologia, ISSN 0301-486X, 12/2015, Volume 180, Issue 5, pp. 317 - 323
Phylogenetic studies highlight Candida africana as an atypical variant within Candida albicans species complex which is dominantly recovered from vaginal... 
Life Sciences | In vitro susceptibility | Medical Microbiology | Microbial Ecology | hwp1 | VVC | Microbiology | Iran | Plant Sciences | C . africana | Eukaryotic Microbiology | C. africana | STRAINS | DUBLINIENSIS | YEASTS | MYCOLOGY | ALBICANS | EPIDEMIOLOGY | Antifungal Agents - pharmacology | Candida - genetics | Humans | Middle Aged | Candida - isolation & purification | Microbial Sensitivity Tests | Young Adult | Candida - classification | Adolescent | Adult | Female | Candida - drug effects | Candidiasis, Vulvovaginal - microbiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Probiotics for prevention of recurrent vulvovaginal candidiasis: A review
by Falagas, Matthew E and Betsi, Gregoria I and Athanasiou, Stavros
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 08/2006, Volume 58, Issue 2, pp. 266 - 272
Vulvovaginal candidiasis (VVC) is a common infection affecting the quality of life of many women. Probiotics havebeen investigated as possible agents for the... 
Candidal vaginitis | Yeast vaginitis | Fungal infections | Bifidobacteria | Lactobacilli | CONTROLLED-TRIAL | INFECTIOUS DISEASES | bifidobacteria | HEALTHY WOMEN | RHAMNOSUS | candidal vaginitis | FLORA | lactobacilli | MICROBIOLOGY | ACIDOPHILUS | yeast vaginitis | fungal infections | BACTERIAL VAGINOSIS | BACTEREMIA | PREGNANT-WOMEN | PHARMACOLOGY & PHARMACY | PEROXIDE-PRODUCING LACTOBACILLI | Candidiasis, Vulvovaginal - prevention & control | Humans | Female | Probiotics - therapeutic use | Lactobacillus - physiology | Vagina - microbiology | Candidiasis, Vulvovaginal - microbiology | Candida albicans - growth & development | Antibiosis | Probiotics - adverse effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Transcriptomic Analysis of Vulvovaginal Candidiasis Identifies a Role for the NLRP3 Inflammasome
by Bruno, Vincent M and Shetty, Amol C and Yano, Junko and Fidel, Paul L and Noverr, Mairi C and Peters, Brian M
mBio, ISSN 2161-2129, 2015, Volume 6, Issue 2, pp. 1 - 15
Treatment of vulvovaginal candidiasis (VVC), caused most frequently by Candida albicans, represents a significant unmet clinical need. C. albicans, as both a... 
ALBICANS VIRULENCE | SECRETED ASPARTYL PROTEINASES | TH17 IMMUNE-RESPONSE | DIFFERENTIAL EXPRESSION | PATTERN-RECOGNITION | FORMATION TRIGGERS ACTIVATION | INTRAVAGINAL CHALLENGE | HOST-DEFENSE | MICROBIOLOGY | ACUTE NEUTROPHIL RESPONSE | RAT MODEL | Inflammasomes - metabolism | Virulence Factors - genetics | NLR Family, Pyrin Domain-Containing 3 Protein | Carrier Proteins - biosynthesis | Mice, Inbred C57BL | Neutrophils - immunology | Molecular Sequence Data | Gene Expression Profiling | Candida albicans - growth & development | Sequence Analysis, DNA | Inflammasomes - genetics | Mice, Knockout | Candida albicans - genetics | Carrier Proteins - genetics | Animals | Candidiasis, Vulvovaginal - pathology | Female | Candidiasis, Vulvovaginal - microbiology | Vagina - pathology | Disease Models, Animal
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Can Lactobacillus fermentum LF10 and Lactobacillus acidophilus LA02 in a Slow-release Vaginal Product be Useful for Prevention of Recurrent Vulvovaginal Candidiasis?: A Clinical Study
by Murina, Filippo and Graziottin, Alessandra and Vicariotto, Franco and De Seta, Francesco
Journal of Clinical Gastroenterology, ISSN 0192-0790, 11/2014, Volume 48 Suppl 1, Proceedings From The 7th Probiotics, Prebiotics & New Foods Meeting Held In Rome On September 8–10, 2013, pp. S102 - S105
OBJECTIVE:To assess the effectiveness of the association of 2 specific strains, Lactobacillus fermentum LF10 (DSM 19187) and Lactobacillus acidophilus LA02... 
Recurrent vulvovaginal candidiasis | Biofilms | Vulvovaginal candidosis | Vaginal microbiota | Lactobacilli | vulvovaginal candidosis | WOMEN | CELLS | recurrent vulvovaginal candidiasis | vaginal microbiota | lactobacilli | ALBICANS | GASTROENTEROLOGY & HEPATOLOGY | biofilms | ASSOCIATION | FLUCONAZOLE | Lactobacillus fermentum - growth & development | Recurrence | Vulva - microbiology | Candidiasis, Vulvovaginal - therapy | Tablets | Humans | Middle Aged | Administration, Intravaginal | Treatment Outcome | Candidiasis, Vulvovaginal - diagnosis | Young Adult | Time Factors | Adult | Female | Italy | Probiotics - therapeutic use | Vagina - microbiology | Candidiasis, Vulvovaginal - microbiology | Lactobacillus acidophilus - growth & development | Delayed-Action Preparations
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Local Treatment of Vulvovaginal Candidosis: General and Practical Considerations
by Neves, Jose das and Pinto, Eugenia and Teixeira, Branca and Dias, Gustavo and Rocha, Patrocinia and Cunha, Teresa and Santos, Barbara and Amaral, Maria H and Bahia, Maria F
Drugs, ISSN 0012-6667, 2008, Volume 68, Issue 13, pp. 1787 - 1802
Vulvovaginal candidosis is a common worldwide female medical problem, occurring mostly in women of childbearing age. Currently available options for the... 
Vulvovaginal candidiasis | Boric acid | Azoles | Topical | Polyenes | Nystatin | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Nystatin, therapeutic use | Vulvovaginal candidiasis, treatment | Azoles, therapeutic use | Boric acid, therapeutic use | Polyenes, therapeutic use | IN-VITRO | RISK-FACTORS | CLINICAL-MANIFESTATIONS | VAGINITIS | TOPICAL FLUCYTOSINE | ANTIFUNGAL ACTIVITY | DOUBLE-BLIND | CANDIDIASIS | BORIC-ACID | PHARMACOLOGY & PHARMACY | TOXICOLOGY | AMPHOTERICIN-B | Antifungal Agents - classification | Nonprescription Drugs - therapeutic use | Humans | Female | Nonprescription Drugs - classification | Candida - drug effects | Candidiasis, Vulvovaginal - microbiology | Candidiasis, Vulvovaginal - drug therapy | Administration, Topical | Antifungal Agents - administration & dosage | Antifungal Agents - therapeutic use | Nonprescription Drugs - administration & dosage | Development and progression | Candidiasis | Care and treatment | Heterocyclic compounds | Health aspects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights